Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New technologies for vaccines.

F Dorner1, J Eibl, P N Barrett

  • 1Biomedical Research Center, Baxter Hyland Immuno, Orth/Donau, Austria. dornerf@baxter.com

Wiener Klinische Wochenschrift
|May 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal glucocorticoid exposure programs adrenal PNMT expression and adult hypertension.

The Journal of endocrinology·2015
Same author

Tick-borne encephalitis vaccines.

Internal medicine journal·2013
Same author

Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.

Cytotechnology·2008
Same author

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

Vaccine·2006
Same author

Systematic evaluation of different approaches for minimizing hemodynamic changes during pneumoperitoneum.

Surgical endoscopy·2006
Same journal

[Vaccination of immunocompromised individuals: Expert opinion - update 2026].

Wiener klinische Wochenschrift·2026
Same journal

Systematic review of clinical evidence for Kneipp medicine.

Wiener klinische Wochenschrift·2026
Same journal

Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

Wiener klinische Wochenschrift·2026
Same journal

Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

Wiener klinische Wochenschrift·2026
Same journal

Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

Wiener klinische Wochenschrift·2026
Same journal

MUW researcher of the month: Dr. Moritz Schaefer.

Wiener klinische Wochenschrift·2026
See all related articles

Vaccination significantly reduces mortality and controls diseases, but ideal vaccines remain elusive. New technologies like recombinant DNA offer promising avenues for developing improved vaccines against infectious agents.

Area of Science:

  • Immunology
  • Microbiology
  • Biotechnology

Background:

  • Vaccination is a cornerstone of global public health, significantly reducing mortality and controlling infectious diseases.
  • Traditional vaccines (live attenuated, inactivated, subunit) have limitations in safety and efficacy.
  • An urgent need exists for novel vaccines against prevalent infectious agents.

Purpose of the Study:

  • To review the impact and mechanisms of traditional vaccines.
  • To explore advanced vaccine development technologies, including recombinant DNA approaches.
  • To highlight the ongoing pursuit of an ideal vaccine.

Main Methods:

  • Review of historical vaccine development and impact.
  • Analysis of current vaccine types and their limitations.

Related Experiment Videos

  • Exploration of modern biotechnological approaches in vaccinology.

    • Main Results:

    • Vaccination has led to substantial reductions in mortality and disease burden, including smallpox eradication.
    • Current vaccine technologies have inherent strengths and weaknesses.
    • Recombinant DNA technology presents new possibilities for vaccine design.

    Conclusions:

    • Despite successes, traditional vaccine development faces challenges in achieving ideal safety and efficacy.
    • Advanced technologies are crucial for developing next-generation vaccines.
    • Continued innovation in vaccinology is essential to address global health threats.